Anna Mae Diehl

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

Naga Chalasani, Zobair M. Younossi, Joel E. Lavine et al. · Hepatology · 2012 · 3.8K citations

Medicine, Internal Medicine, Gastroenterology +16

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

Arun J. Sanyal, Naga Chalasani, Kris V. Kowdley et al. · New England Journal of Medicine · 2010 · 3.3K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +7

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

Brent A. Neuschwander‐Tetri, Rohit Loomba, Arun J. Sanyal et al. · The Lancet · 2014 · 2.2K citations

Medicine, Internal Medicine, Pharmacology +14

The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

Naga Chalasani, Zobair M. Younossi, Joel E. Lavine et al. · Gastroenterology · 2012 · 1.8K citations · Full text

Medicine, Internal Medicine, Gastroenterology +15

The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

Jérôme Boursier, Olaf Mueller, Matthieu Barret et al. · Hepatology · 2015 · 1.5K citations

Life Sciences, Microbiology, Pathology +17